N-Acetylcysteine (NAC) for Skin Picking: What the Research Says

The one trial that's actually about skin picking

Most pages about NAC and picking cite Jon Grant's 2009 hair-pulling study. That study exists and it's good, but it isn't about skin. The findings for hair pulling are a separate literature. The skin-picking trial came seven years later.

Grant and colleagues randomized 66 adults with skin picking disorder across the University of Minnesota and the University of Chicago, running from 2011 to 2015 and published in JAMA Psychiatry in 2016. Thirty-five got NAC at a dosing range of 1,200 to 3,000 mg a day, thirty-one got placebo, for twelve weeks. Fifty-nine of the 66 were women, average age 34.8.

Three things are worth pulling out of that.

"Much improved" is not "stopped." It's a clinician's single global judgment on a seven-point scale. It means the person is visibly better than they were. It does not mean the picking ended, and the trial didn't report anyone as cured.

The 47% is a percentage of completers. Thirteen of the 66 people randomized didn't finish. Counted against everyone who started NAC, 15 out of 35 is 43%. Neither figure is wrong, but the more generous one is the one that travels.

What the rest of the evidence looks like

One positive trial is one positive trial. The surrounding literature is thinner and less flattering, and it's the part almost no consumer page includes.

A retrospective cohort followed 28 adults given 1,200 to 2,400 mg a day for twelve weeks. Of the thirteen who completed, 61.5% showed a positive response, which sounds strong until you read the next sentence: 40% stopped before the recommended trial period because their picking wasn't improving.

Two studies in Prader-Willi syndrome, where skin picking is common, point opposite ways. An open-label pilot in 35 children and adults on 450 to 1,200 mg a day reported reduced picking in everyone and complete resolution in 71%. A German retrospective study of 14 adults on 1,800 to 2,400 mg found six improved, six unchanged, and two worse.

The 2022 review that collected all of this, published by dermatologists at Weill Cornell, ends where the evidence ends: there is currently not enough evidence to firmly recommend NAC for excoriation disorder.

Behavioral treatment sits differently in this literature. A 2016 meta-analysis of skin picking treatments found that every intervention studied, including the inactive control conditions, produced significant improvement over a short trial. Only behavioral treatments beat inactive controls. That meta-analysis was searched in 2013, before the NAC trial existed, so it says nothing about NAC directly. What it says is that the bar for a skin-picking medication is unusually high, because people in these trials get better anyway.

The placebo problem, which is specific to this condition

This is the finding that should change how you interpret your own experience, and it's almost entirely absent from the pages that rank for this query.

In an earlier crossover trial, researchers gave 69 people with skin picking disorder an inert pill and told them it was N-acetylcysteine. After two weeks the group showed a clinically meaningful reduction in picking, plus lower perceived stress and fewer difficulties with emotion regulation. The pills contained nothing.

Two practical consequences follow. The first is that if you start NAC and feel better in week two, you have learned almost nothing, because expectation plus the act of tracking yourself reliably produces that. The second is that daily monitoring on its own moves the needle, which is a strange sort of good news: the thing you'd do to evaluate the supplement is itself mildly therapeutic.

How it's thought to work

Briefly, because mechanism is rarely why anyone lands on this page.

NAC is a precursor to glutathione, and it appears to restore extracellular glutamate concentration in the nucleus accumbens, a region involved in reward and compulsive behavior. The working theory is that this makes a compulsive urge marginally easier to decline. It's the same rationale behind studying NAC in gambling and substance use, and behind memantine, a different glutamate modulator.

That theory is also why NAC and SSRIs are not interchangeable. Antidepressants act on serotonin, and the meta-analytic evidence that they beat placebo for skin picking specifically is weak. Where medication sits relative to everything else is covered in the full guide to stopping skin picking.

Doses used in the research, and the schedule

Nothing in this section is an instruction. These are the numbers that appear in trials and in what Grant has described about his own prescribing, and they exist so you can have a specific conversation with a doctor rather than a vague one.

The 2016 skin-picking trial used 1,200 to 3,000 mg a day. Grant has since said he starts at 1,200 mg rather than 600 mg, because in his experience the lower dose helps very few people. Typical titration described in clinical write-ups is 600 mg twice daily to start, moving up over two to four weeks toward 2,400 to 3,000 mg if it's tolerated and not yet working.

Splitting the dose isn't arbitrary. Grant estimates NAC stays in the system roughly eight to ten hours, and as little as three to five for some people, which is why he divides it and suggests weighting it toward whenever your picking clusters. If your worst window is late evening, a morning-and-dinner split covers it better than a single morning capsule.

Two form notes. The capsule form is what was studied. Grant specifically warns off the liquid preparation sold in pharmacies, which causes significant side effects and is intended for a different purpose. And because of how NAC works in the body, he suggests taking it with a multivitamin plus vitamin C during extended use, while being clear that the evidence for what counts as extended is unsettled.

Twelve weeks, and how to judge it

The trials that found an effect ran twelve weeks. In the hair-pulling study, the point where NAC separated from placebo was around week nine.

So a two-week trial tells you nothing except how your stomach handles it. A four-week trial tells you almost nothing. If you and your doctor decide to try NAC, the commitment is roughly three months at a dose that was actually titrated up, with something written down at the start so you can compare against it later.

At twelve weeks the fork is straightforward. Clearly better on your own numbers, and it's reasonable to discuss continuing, and to ask how long. Nothing, or a change you can't distinguish from a normal fluctuation, and it's reasonable to stop and spend the money and attention elsewhere. Roughly half the people in the trial were in that second group.

Side effects and interactions

NAC was well tolerated in the skin-picking trial. Nobody withdrew because of side effects.

The cautions matter more than the side effects, and they're the part most consumer pages skip.

Two footnotes on things you may read elsewhere. The 18% anaphylactoid reaction rate that appears in some NAC safety writeups comes from intravenous NAC given in hospital for paracetamol overdose, and clinical references note it is not an issue with the oral route. And the widely repeated kidney stone warning traces largely to individual accounts rather than trial data, though it's part of why vitamin C is commonly recommended alongside long-term use.

The part nobody mentions: you can't fully trust the bottle

NAC has an odd legal status in the United States. The FDA approved it as a drug on 14 September 1963, which under the Food, Drug and Cosmetic Act means it's technically excluded from the definition of a dietary supplement. The agency spelled this out, then in August 2022 issued final guidance saying it would exercise enforcement discretion and leave NAC supplements on the shelf while it works through a possible rulemaking. Its own review, as of that guidance, had not revealed safety concerns.

Grant, who ran the trial, is unusually candid about this. He bought the study supply from one company because they could document product quality, and says plainly that he doesn't know enough about supplement manufacturers to recommend particular ones. The workable version of that advice is to look for third-party verification on the bottle. USP and NSF both test whether contents match the label and screen for contaminants. Neither tells you anything about whether it'll work for you.

Who this isn't for

NAC is not appropriate to try on your own if you have asthma, if you take nitroglycerin, if you're pregnant or breastfeeding, or if you're under 18 and haven't had this discussed with a pediatrician. Grant has used it in adolescents at the same 1,200 to 2,400 mg range after behavioral therapy failed, and describes it as apparently safe in that group, but the controlled trial was in adults only.

It's also not the right first move if you haven't tried behavioral treatment. That isn't a moral position, it's what the evidence supports: behavioral treatment is the only approach that has beaten inactive controls in a meta-analysis of skin picking treatments, and the NAC trial deliberately did not combine the two. Grant's own recommendation is that anyone taking NAC should also be doing behavior therapy. The protocol itself is laid out in this step-by-step guide to habit reversal training.

Where NAC actually fits

Somewhere between "worth asking about" and "the thing that fixes this."

Realistically, for a lot of people, it's the cheapest door into treating this at all, because a therapist trained in body-focused repetitive behaviors is hard to find and expensive when you find one. That's a legitimate reason to ask about it. It's not a reason to let it stand in for the behavioral work, because the behavioral work is what the evidence actually supports, and NAC's own researchers say so. If you're still working out whether what you have meets the criteria, start with the foundational overview of skin picking disorder.

The version of this that gives you the best odds looks like: a conversation with your doctor about whether NAC is safe alongside what you already take, a proper twelve-week trial at a titrated dose, a daily log kept from day one so you can judge it fairly, and habit reversal training running underneath the whole thing.

SkinAware covers two of those four. It has episode and urge logging, which is the daily baseline you'd need to judge a supplement trial at all, and an HRT course of four modules covering the habit loop, trigger mapping, competing responses, and maintenance.

Frequently Asked Questions